Becton, Dickinson & Co. (BDX) Misses Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts BDX Hot Sheet
Price: $183.58 --0%
Financial Fact:
Cost of products sold: 1.68B
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Cost of products sold: 1.68B
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Becton, Dickinson & Co. (NYSE: BDX) reported Q3 EPS of $1.65, $0.02 worse than the analyst estimate of $1.67. Revenue for the quarter came in at $2.16 billion versus the consensus estimate of $2.14 billion.
For earnings history and earnings-related data on Becton, Dickinson & Co. (BDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Ascendis Pharma (ASND) Tops Q2 EPS by 132c
- CorMedix (CRMD) Tops Q2 EPS by 6c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
